The Elevated Tee with Matt McKay

Elder Answers with Michael McGuire, 10:00 a.m. - 10:30 a.m.

 

Extremist past mars makeover of France's far-right party

Sunday, 8:20 AM

In this Saturday Nov. 29, 2014 file photo, French far-right Front National leader Marine Le Pen and her father Jean-Marie Le Pen applaud during the 15th congress of the party, in Lyon, central France. A pact of sorts may end the bloodletting between Le Pen and her 86-year-old father, Jean-Marie Le Pen, a party founder whose latest anti-Semitic remarks have tripped up the efforts of his daughter to give the National Front a new look. She announced on national television she will oppose his candidacy in December regional elections. (AP Photo/Laurent Cipriani, File)PARIS (AP) — The timing could not have been worse. Daggers were already drawn in a father-daughter duel within the far-right National Front when a judicial investigation began circling closer and closer to the party leadership.


Russia beats Germany in Fed Cup semi to book final vs Czechs

Sunday, 8:18 AM

SOCHI, Russia (AP) — Russia reached the Fed Cup final Sunday, sealing victory at home over Germany in the last doubles rubber.

Austerity's legacy: British election focused on UK economy

Sunday, 8:13 AM

FILE - In this Friday April 17, 2015 file photo Britain's Prime Minister David Cameron addresses Fujitsu employees in Birmingham, England. Prime Minister David Cameron and his main opponent, Labour leader Ed Miliband, agree on one thing going into Britain’s May 7 election: voters should choose the next leader based on the health of the economy. (Peter Macdiarmid/Pool Photo via AP, File)LONDON (AP) — Prime Minister David Cameron and his main opponent agree on one thing going into Britain's May 7 election: Voters should choose the next leader based on the health of the economy.


Researcher denied flight after tweet poking United security

Sunday, 7:59 AM

WASHINGTON (AP) — United Airlines stopped a prominent security researcher from boarding a California-bound flight late Saturday, following a social media post by the researcher days earlier suggesting the airline's onboard systems could be hacked.

Thai Kiradech prevails in playoff to win in Shenzhen

Sunday, 3:52 AM

Kiradech Aphibarnrat of Thailand watches his tee shot during the first round of the British Open Championship at the Royal Liverpool Golf Club in Hoylake(Reuters) - Big-hitting Thai Kiradech Aphibarnrat eagled the penultimate hole to force a playoff and then prevailed over Chinese teen Li Hao-tong at the Shenzhen International to claim his second European Tour title on Sunday. The 19-year-old Chinese golfer signed off with a five-under-par 67 in his regular round to aggregate 12-under, hoping to be the first from his country to win an European Tour event on home soil. Overnight leader Kiradech, however, had other ideas as the Thai, having dropped four bogeys by then, eagled the 17th to draw level before squandering a putt to win the tournament on the final hole. "Special thanks to my caddie, he was always pushing me," the 25-year-old Kiradech, whose only other European Tour victory came at the 2013 Malaysian Open, said.


Golf-Thai Kiradech prevails in playoff to win in Shenzhen

Sunday, 3:35 AM

Big-hitting Thai Kiradech Aphibarnrat eagled the penultimate hole to force a playoff and then prevailed over Chinese teen Li Hao-tong at the Shenzhen International to claim his second European Tour title on Sunday. The 19-year-old Chinese golfer signed off with a five-under-par 67 in his regular round to aggregate 12-under, hoping to be the first from his country to win an European Tour event on home soil. Overnight leader Kiradech, however, had other ideas as the Thai, having dropped four bogeys by then, eagled the 17th to draw level before squandering a putt to win the tournament on the final hole. "Special thanks to my caddie, he was always pushing me," the 25-year-old Kiradech, whose only other European Tour victory came at the 2013 Malaysian Open, said.

NY's Cuomo to be first gov. to visit Cuba as ties reopen

Sunday, 8:21 AM

FILE - In this Aug. 13, 2014 file photo, New York Gov. Andrew Cuomo speaks during his meeting with Israel's President Reuven Rivlin, at the President's residence in Jerusalem. Cuomo, who visited Israel last year in a rare trip outside the U.S., has announced a series of overseas trade missions. He will be the first sitting American governor to visit Cuba since the recent thaw in relations with the communist nation. (AP Photo/Sebastian Scheiner, File)ALBANY, N.Y. (AP) — New York Gov. Andrew Cuomo is heading to Havana, the first American governor to visit Cuba since the recent thaw in relations with the communist nation. Whether his trade mission generates anything more than headlines, however, remains to be seen.


Canadian shrimp imports up as Maine fishery remains closed

Sunday, 8:15 AM

PORTLAND, Maine (AP) — The value of Canada's cold water shrimp exports to the United States is growing as the Gulf of Maine's fishery remains closed to fishing.

Japan, U.S. report progress on trade talks, though Tokyo stands tough on rice

Sunday, 7:31 AM

Japan's Economics Minister Amari shakes hands with U.S. Trade Representative Froman ahead of their meeting in TokyoJapan and the United States reported progress in top-level trade talks on Sunday that could pave the way for a broader trans-Pacific trade deal, although Tokyo cautioned that a bilateral accord was unlikely in time for a summit next week. Japan's Economy Minister Akira Amari and U.S. Trade Representative Michael Froman both said they had made good progress in the first of two days of cabinet-level discussions. "We exchanged opinions about areas where Japan and the U.S. will cooperate in dealing with others" in the multilateral talks, Amari told reporters. Access to Japan's farm market and the U.S. car market remain obstacles to a bilateral deal between the two nations, vital to the success of a long-delayed Trans-Pacific Partnership (TPP) pact.


China makes big cut in bank reserve requirement to fight slowdown

Sunday, 7:28 AM

A Chinese national flag flutters outside the headquarters of the People's Bank of China in BeijingChina's central bank on Sunday cut the amount of cash that banks must hold as reserves, the second industry-wide cut in two months, adding more liquidity to the world's second-biggest economy to help spur bank lending and combat slowing growth. The People's Bank of China (PBOC) lowered the reserve requirement ratio (RRR) for all banks by 100 basis points to 18.5 percent, effective from April 20, the central bank said in a statement on its website www.pbc.gov.cn. "Though the growth in the first quarter met the official target of around 7 percent for 2015, the slowdown in several areas, including industrial output and retail sales, has caused concern," said a report published by the official Xinhua news service covering the announcement. The latest cut, the deepest single reduction since the depth of the global crisis in 2008, shows how the central bank is stepping up efforts to ward off a sharp slowdown in the economy.


Teva shares slide on generic Copaxone fears

Sunday, 6:07 AM

A sign bearing the logo of Teva is seen in JerusalemBy Steven Scheer and Tova Cohen TEL AVIV (Reuters) - Teva Pharmaceutical Industries shares slid five percent on Sunday after U.S. regulators approved a generic version of its top-selling multiple sclerosis drug and amid reports it was mulling a bid for rival Mylan. Teva's Tel Aviv shares fell to 249.80 shekels ($64) late on Sunday, the first day of trading since both news hit the market on Thursday after Israel's market closed for the weekend. Teva's New York-listed shares fell 3.8 percent on Thursday but gained 2.2 percent on Friday, ending the week at $64.91. In a potentially major blow for Teva, the U.S. Food and Drug Administration approved the first generic version of multiple sclerosis drug Copaxone, which accounts for about half the company's profit.


Merck's Keytruda shrinks lung cancer tumors, FDA approval sought

Sunday, 5:35 AM

Merck & Co Inc's Keytruda, approved for treating melanoma, was shown in a trial to shrink tumors in nearly half of advanced lung cancer patients with high levels of a protein used by tumors to evade the body's own disease-fighting cells. The company said it has filed for U.S. Food and Drug Administration approval of the drug as a treatment for patients with non-small cell lung cancer (NSCLC) whose disease has worsened despite previous treatment. Keytruda, also known as pembrolizumab, belongs to a new class of drugs designed to help the immune system fend off cancer by blocking a protein known as Programmed Death receptor (PD-1), or a related target known as PD-L1. Merck said its FDA lung cancer filing is for patients with both squamous and non-squamous NSCLC.